Speakers from leading companies in the drug discovery arena presented at Maybridge's highly successful third annual Outsourcing Lead Discovery scientific workshop
The workshop, held in Bregenz, Austria, on 23-24 October 2003, provided a forum for the discussion of ideas, strategies and technologies in the research outsourcing marketplace and was attended by more than 30 delegates from central European countries.
The purpose of the workshop, organised by Christof B”hler, was to increase the efficiency of lead discovery through the sharing of ideas and strategies.
Maybridge welcomed eight speakers representing companies from a broad range of technologies, a pre-requisite in today's pharmaceutical discovery environment.
These included Axovan, Cresset BioMolecular Discovery, Mimotopes, Novartis Pharma, Sireen, Solvay, Genetics Company, and Tripos.
Talks focused on integration of external partners, integrating drug development and collaborations of outsourcing within lead finding.
Prof Gerd Schnorrenberg, Boehringer Ingleheim, chaired an informative round table discussion on the pros and cons of outsourcing.
This informative workshop has strengthened Maybridge's recognition as a major provider of products and contract research services to the drug discovery industry.
